Birdwatch Note
2024-10-02 12:21:57 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
札幌大谷大学は医学部どころか科学分野の学部すらなく、素人の理事長がSNS等で得たデマを拡散しているだけです https://www.sapporo-otani.ac.jp/department/ ↓文科省の苦情窓口 https://www.inquiry.mext.go.jp/inquiry27/ コスタイベ(レプリコン)の治験ではプラセボ群で16(うち、新型コロナ9)の死亡が接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001266060.pdf 従来型についても、日本を含めた世界中の継続かつ徹底した科学的検証で安全性が証明されています https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html IF値の高い医学誌・科学誌の査読済論文、WHOや先進国民主主義の政府機関の公式発表等の原典を参照しましょう。 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#34 https://togetter.com/li/2416068 https://togetter.com/li/2131189 https://togetter.com/li/2174198
Written by EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1841238380379849195
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1841453568093827117
- noteId - 1841453568093827117
- participantId -
- noteAuthorParticipantId - EE7192EF0B1C47D8A3430C3E070DA2A0BFAA58717F9133404318E9D7666B1A00 Participant Details
- createdAtMillis - 1727871717843
- tweetId - 1841238380379849195
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- 札幌大谷大学は医学部どころか科学分野の学部すらなく、素人の理事長がSNS等で得たデマを拡散しているだけです https://www.sapporo-otani.ac.jp/department/ ↓文科省の苦情窓口 https://www.inquiry.mext.go.jp/inquiry27/ コスタイベ(レプリコン)の治験ではプラセボ群で16(うち、新型コロナ9)の死亡が接種群では5(うち、新型コロナ1)と減少しており、特段の懸念は認められません https://doi.org/10.1038/s41467-024-47905-1 https://www.mhlw.go.jp/content/10906000/001266060.pdf 従来型についても、日本を含めた世界中の継続かつ徹底した科学的検証で安全性が証明されています https://www.mhlw.go.jp/content/10900000/000796742.pdf https://www.niid.go.jp/niid/ja/others.html https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-vaccines-safety https://doi.org/10.1016/S1473-3099(22)00320-6 https://warp.ndl.go.jp/info:ndljp/pid/13123205/www.cov19-vaccine.mhlw.go.jp/qa/0081.html https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#29 https://www.mhlw.go.jp/stf/shingi/shingi-kousei_284075.html IF値の高い医学誌・科学誌の査読済論文、WHOや先進国民主主義の政府機関の公式発表等の原典を参照しましょう。 https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/vaccine_qa.html#34 https://togetter.com/li/2416068 https://togetter.com/li/2131189 https://togetter.com/li/2174198
Note Ratings
rated at | rated by | |
2024-10-02 18:02:09 -0500 | Rating Details | |
2024-10-02 17:44:53 -0500 | Rating Details | |
2024-10-02 16:42:53 -0500 | Rating Details | |
2024-10-02 13:41:39 -0500 | Rating Details | |
2024-10-02 10:38:04 -0500 | Rating Details | |
2024-10-02 10:15:05 -0500 | Rating Details | |
2024-10-02 10:03:58 -0500 | Rating Details | |
2024-10-02 08:46:09 -0500 | Rating Details | |
2024-10-02 08:28:12 -0500 | Rating Details | |
2024-10-02 08:06:09 -0500 | Rating Details | |
2024-10-02 07:57:17 -0500 | Rating Details | |
2024-10-02 07:34:42 -0500 | Rating Details | |
2024-10-03 18:45:21 -0500 | Rating Details | |
2024-10-03 05:23:23 -0500 | Rating Details | |
2024-10-02 07:34:37 -0500 | Rating Details | |
2024-10-02 07:29:59 -0500 | Rating Details | |
2024-10-11 06:31:20 -0500 | Rating Details | |
2024-10-08 20:16:05 -0500 | Rating Details | |
2024-10-03 21:47:40 -0500 | Rating Details | |
2024-10-03 02:30:06 -0500 | Rating Details | |
2024-10-02 19:02:48 -0500 | Rating Details | |
2024-10-02 07:34:13 -0500 | Rating Details | |
2024-10-08 19:02:59 -0500 | Rating Details | |
2024-10-11 07:30:53 -0500 | Rating Details |